Immune response to genital papillomavirus infections in women. Prospects for the development of a vaccine against cervical cancer.
Gissmann
L
L
Forschungsschwerpunkt Angewandte Tumorvirologie Deutsches Krebsforschungszentrum, Heidelberg, Germany.
Jochmus
I
I
Nindl
I
I
Müller
M
M
D005260:Female; D006801:Humans; D016233:Immunotherapy, Active; D027383:Papillomaviridae / Q000276:immunology*; D053918:Papillomavirus Vaccines; D014412:Tumor Virus Infections / Q000276:immunology / Q000517:prevention & control*; D002577:Uterine Cervical Diseases / Q000517:prevention & control; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000517:prevention & control*; D014765:Viral Vaccines / Q000276:immunology
D053918:Papillomavirus Vaccines; D014765:Viral Vaccines